INmune Bio Inc. Common stock

INMBNASDAQ • USD
0.99 USD
↗ 0.04 (4.08%)🟢LIVE (AS OF 02:24 PM EST)
🟢Market: OPEN

INmune Bio Inc. Common stock (INMB) trades at $0.99 per share. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Nov 16, 2026.

Open?$0.95
High?$1.04
Low?$0.92
Prev. Close?$0.95
Volume?501.5K
Avg. Volume?316.4K
VWAP?$1.00
Rel. Volume?1.59x
Bid / Ask
Bid?$0.83 × 100
Ask?$1.12 × 100
Spread?$0.29
Midpoint?$0.98
Valuation & Ratios
Market Cap?29.4M
Shares Out?31.0M
Float?24.7M
Float %?88.8%
P/E Ratio?N/A
P/B Ratio?1.63
EPS?-$0.55
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.
Employees
21
Market Cap
32.5M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2019-02-04
Address
225 NE MIZNER BLVD, SUITE 640
BOCA RATON, FL 33432
Phone: (858) 964-3720
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
50
Short Sent.?
53
Piotroski F-Score?0/9Weak
Altman Z-Score?-11.06Distress
Confidence?53%Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?10.78%High
Short Interest?2.7M
Days to Cover?14.4
Free Float24.7M
Avg Daily Volume184.7K
Settlement Date2026-10-30
Financial Health
Current Ratio?6.41Strong
Quick Ratio?6.41Strong
Cash Ratio?5.60Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
84
1.63CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.8CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-93.8%WEAK▾
ROA?
S&P
3
-78.8%WEAK▾
Cash Flow & Enterprise
FCF?$-13486000
Enterprise Value?$13.1M
Fundamentals ratios updated end of day